Sub-Saharan African region news, resources and funding for global health researchers
NIH supports a diverse mix of research projects in Sub-Saharan Africa with significant activities in approximately 20 African countries. About a third of the funding supports groundbreaking research and research training on HIV/AIDS and sexually transmitted diseases, including a substantial effort to study mother-to-child transmission of HIV. Around 20 percent funds research on other infectious diseases, ranging from population-based research on malaria, schistosomiasis and leishmaniasis, to molecular research on vectors and parasites. Chronic disease research makes up about 12 percent of the research portfolio, with the remainder devoted to child development, biodiversity, basic research and other studies.
Countries in Region
Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Democratic Republic of the Congo, Republic of Congo, Côte d’Ivoire, Djibouti, Equatorial Guinea, Eritrea, Eswatini, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Libya, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Morocco, Namibia, Niger, Nigeria, Rwanda, São Tomé and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Tanzania, Togo, Tunisia, Uganda, Zambia, Zimbabwe
NIH Funded Research Impacting Sub-Saharan Africa
- Through grant funding to U.S. universities, NIH facilitates international collaboration in Sub-Saharan Africa in all areas of the biomedical and behavioral sciences.
Fogarty/NIH News
-
The HIV-2 proviral landscape is dominated by defective proviruses, co-authored by Fogarty grant recipient Roger Shapiro and Fogarty trainee Catherine K. Koofhethile
AIDS, March 1, 2024 -
A researcher-exchange programme made me a better doctor at home and abroad – profile of former Fogarty Global Health Fellow Caleb Skipper
Nature, February 12, 2024 -
Novel functional insights into ischemic stroke biology provided by the first genome-wide association study of stroke in indigenous Africans, co-authored by Fogarty grant recipients Bruce Ovbiagele and Mayowa O. Owolabi, Fogarty trainees Onoja Akpa, Reginald Obiako, Godwin O. Osaigbovo, Abiodun Adeoye, Okechukwu S. Ogah, Godwin Ogbole, and Akinkunmi Okekunle, and National Human Genome Research Institute’s Charles Rotimi
Genome Medicine, February 5, 2024 -
Hepatitis B surface antigen loss in individuals with chronic hepatitis B virus and HIV-1 infections in Botswana, co-authored by Fogarty grant recipients Roger Shapiro, Joseph Makhema, and Shahin Lockman, Fogarty Emerging Global Leader Sikhulile Moyo, and Fogarty trainees Mompati Mmalane and Simani Gaseitsiwe
AIDS, February 1, 2024 -
Development, acceptability and usability of culturally appropriate survivor narrative videos for breast cancer treatment in Botswana: a pilot study, co-authored by Fogarty International Research Scientist Yehoda M. Martei
BMJ Open, January 2024 -
Public health and research ethics education: the experience of developing a new cadre of bioethicists at a Ugandan institution, co-authored by Fogarty grant recipients Gertrude N. Kiwanuka and Sana Loue
BMC Medical Education, January 3, 2024 -
Building capacity for network meta-analysis in Sub-Saharan Africa: reflections and future direction, co-authored by Fogarty grant recipient Taryn Young
Systematic Reviews, January 2, 2024 -
Impact of a livelihood intervention on gender roles and relationship power among people with HIV, co-authored by Fogarty grant recipients Craig R. Cohen, Sheri D. Weiser, and Elizabeth A. Bukusi
AIDS, January 1, 2024 -
Rapid Onsite Evaluation for Specimen Adequacy and Triage of Breast Masses in a Low-Resource Setting, co-authored by Fogarty grant recipients Elia J. Mmbaga and Katherine Van Loon, and Fogarty Global Health Fellow Asteria H. Kimambo
Archives of Pathology & Laboratory Medicine, January 1, 2024 - Biomarker-confirmed suboptimal adherence to isoniazid preventive therapy among children with HIV in western Kenya, co-authored by former Fogarty Global Health Fellow Dickens Otieno Onyango and Sylvia M. Lacourse and former Fogarty Global Health Scholar John Kinuthia
AIDS, January 1, 2024 -
A Patient-Centered, Combination Intervention to Support Adherence to HIV Pre-exposure Prophylaxis During Pregnancy and Breastfeeding: A Randomized Pilot Study in Malawi, co-authored by Fogarty grant recipient Benjamin Chi, Fogarty trainees Twambilile Phanga, Twaambo Hamoonga, Sam Phiri, and Wilbroad Mutale, and former Fogarty Global Health Fellows Friday Saidi, Kellie Freeborn, and Nora Rosenberg
The Journal of Acquired Immune Deficiency Syndrome, January 2024 -
Utilization of opportunistic cervical cancer screening in Nigeria, co-authored by Fogarty Emerging Global Leader Jonah Musa
Cancer Causes and Control, January 2024 - Ethical considerations for biobanking and use of genomics data in Africa: a narrative review, co-authored by Fogarty trainees Mary Amoakoh-Coleman and James Abugri
BMC Medical Ethics, December 5, 2023
Funding/Training Opportunities
U.S. Government Resources
Other Resources
Fogarty Contact
Stacy Wallick, MPH
Regional Program Director, Sub-Saharan Africa
Division of International Relations
Fogarty International Center
National Institutes of Health
Building 31 Room B2C11
Bethesda, MD 20892-2220
Telephone: 301-496-2091
FAX: 301-480-3414
Email (preferred):
Stacy.Wallick@nih.gov
Updated February 26, 2024